Filtered By:
Condition: Pregnancy

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 4410 results found since Jan 2013.

Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception
CONCLUSIONS: There are no comparative studies assessing risk of thromboembolism in COVID-19 patients who use hormonal contraception, which was the primary objective of this review. Very little evidence exists examining the risk of increased COVID-19 disease severity for combined hormonal contraception users compared to non-users of hormonal contraception, and the evidence that does exist is of very low certainty. The odds of hospitalization for COVID-19 positive users of combined hormonal contraceptives may be slightly decreased compared with those of hormonal contraceptive non-users, but the evidence is very uncertain as ...
Source: Cochrane Database of Systematic Reviews - May 15, 2023 Category: General Medicine Authors: Shaalini Ramanadhan Katie Hansen Jillian T Henderson Megan A Cohen Robin Paynter Alison Edelman Source Type: research

Viruses, Vol. 15, Pages 1167: Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
ristos Savopoulos In the years of Coronavirus Disease 2019 (COVID-19), various treatment options have been utilized. COVID-19 continues to circulate in the global population, and the evolution of the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has posed significant challenges to the treatment and prevention of infection. Remdesivir (RDV), an anti-viral agent with in vitro efficacy against coronaviruses, is a potent and safe treatment as suggested by a plethora of in vitro and in vivo studies and clinical trials. Emerging real-world data have confirmed its effectiveness, and there are currently da...
Source: Viruses - May 14, 2023 Category: Virology Authors: Karolina Akinosoglou Emmanouil Angelos Rigopoulos Georgios Schinas Georgia Kaiafa Eleni Polyzou Stamatia Tsoupra Argyrios Tzouvelekis Charalambos Gogos Christos Savopoulos Tags: Review Source Type: research

Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination
Obstet Gynecol. 2023 May 11. doi: 10.1097/AOG.0000000000005241. Online ahead of print.ABSTRACTIn this multisite, observational, matched cohort study of more than 80,000 pregnant people, receipt of an mRNA monovalent coronavirus disease 2019 (COVID-19) booster vaccination in pregnancy was not associated with increased risk for thrombocytopenia, myocarditis, venous thromboembolism, ischemic stroke, or other serious adverse events within 21 or 42 days after booster vaccination. The mRNA monovalent COVID-19 booster in pregnancy was associated with an increased risk for medically attended malaise or fatigue within 7 days of vac...
Source: Obstetrics and Gynecology - May 11, 2023 Category: OBGYN Authors: Malini B DeSilva Jacob Haapala Gabriela Vazquez-Benitez Thomas G Boyce Candace C Fuller Matthew F Daley Darios Getahun Simon J Hambidge Heather S Lipkind Allison L Naleway Jennifer C Nelson Kimberly K Vesco Eric S Weintraub Joshua T B Williams Ousseny Zer Source Type: research

COVID-19 mRNA vaccination status and concerns among pregnant women in Japan: a multicenter questionnaire survey
mRNA vaccination is an effective, safe, and widespread strategy for protecting pregnant women against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, information...
Source: BMC Pregnancy and Childbirth - May 9, 2023 Category: OBGYN Authors: Ken Takahashi, Osamu Samura, Akihiro Hasegawa, Haruna Okubo, Keiji Morimoto, Madoka Horiya, Aikou Okamoto, Daigo Ochiai, Mamoru Tanaka, Masaki Sekiguchi, Naoyuki Miyasaka, Yuto Suzuki, Tsutomu Tabata, Eijiro Hayata, Masahiko Nakata, Tomoo Suzuki & hellip; Tags: Research Source Type: research

A propensity score matching study: the prevalence of mental health problems among pregnant women at first antenatal care increased in Chongqing during the first wave of the COVID-19 pandemic - Guo J, Li X, He J, Ai M, Gan Y, Zhang Q, Zheng A, Chen W, Chen L, Liang S, Yu X, Kuang L.
BACKGROUND: The 2019 coronavirus disease (COVID-19) pandemic increased the risks of mental health challenges, especially anxiety and depression. However, the impact of COVID-19 on mental health during pregnancy has not been fully established. Therefore, we...
Source: SafetyLit - May 5, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Titer Levels in Pregnant Individuals After Infection, Vaccination, or Both
We examined differences in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody responses in pregnant individuals with natural, vaccine-induced, or combined immunity. Participants had live or nonlive births between 2020 and 2022, were seropositive (SARS-CoV-2 spike protein, anti-S), and had available mRNA vaccination and infection information (n=260). We compared titer levels among three immunity profiles: 1) natural immunity (n=191), 2) vaccine-induced immunity (n=37), and 3) combined immunity (ie, natural and vaccine-induced immunity; n=32). We applied linear regression to compare anti-S titers between t...
Source: Obstetrics and Gynecology - May 4, 2023 Category: OBGYN Authors: Christina L Marshall Elianna Kaplowitz Erona Ibroci Kyle Chung Frederieke A J Gigase Molly Lieber Mara Graziani Sophie Ohrn Jezelle Lynch Juliana Castro Rushna Tubassum Farida Mutawakil Rebecca Jessel Nina Molenaar Anna-Sophie Rommel Rhoda S Sperling Eliz Source Type: research